Well observed, ALA's EV $150m and still struggling to get an IND granted, IMU's EV $300m with 5 clinical trials that have already produced incredible and never seen before successfully data. Not to mention CHM's ZERO valuation based on 3 trials and the GBM one of them already being a Ph1b expansion trial to lead over into a rego trial. What is the market doing? If ALA is correctly valued, how in the world can IMU be worth just $300m and CHM's EV ZERO?
GLTA
Media Thread, page-14694
-
- There are more pages in this discussion • 410 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
-0.001(1.89%) |
Mkt cap ! $382.1M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.2¢ | $216.1K | 4.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 1854997 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 382882 | 4 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |